Why do we not have a cure for rheumatoid arthritis?

被引:0
|
作者
Hani D El-Gabalawy
Peter E Lipsky
机构
[1] University of Manitoba,Arthritis Centre
[2] National Institute of Arthritis and Musculoskeletal and Skin Diseases,Intramural Research Program
关键词
etiology; prevention; rheumatoid arthritis; therapy;
D O I
暂无
中图分类号
学科分类号
摘要
There are currently unprecedented opportunities to treat rheumatoid arthritis using well-designed, highly effective, targeted therapies. This will result in a substantial improvement in the outcome of this disorder for most affected individuals, if they can afford these therapies. Yet our lack of understanding of the basic mechanisms that initiate and sustain this disease remains a major obstacle in the search for a definitive cure. It is possible, if not likely, that our best approach will be to identify individuals at risk and devise reliable, safe methods of preventing the disease before it occurs. The means to do this are currently unknown but should serve as a major focus of research.
引用
收藏
相关论文
共 50 条
  • [31] Children - Why Do We Have Them?
    Berman, Harold H.
    PSYCHIATRIC QUARTERLY, 1933, 7 (03) : 522 - 524
  • [32] Why do we have automobile accidents?
    Lauer, A. R.
    JOURNAL OF APPLIED PSYCHOLOGY, 1946, 30 (02) : 194 - 195
  • [33] Why don't we just do what we have to do?
    Pasqualotto, AC
    JOURNAL OF INFECTION, 2005, 51 (03) : 260 - 261
  • [34] Medication adherence in patients with rheumatoid arthritis: why do patients not take what we prescribe?
    Peter K. K. Wong
    Rheumatology International, 2016, 36 : 1535 - 1542
  • [35] Will we have and why do we need an Ebola vaccine?
    Hans-Dieter Klenk
    Nature Medicine, 2000, 6 : 1322 - 1323
  • [36] Medication adherence in patients with rheumatoid arthritis: why do patients not take what we prescribe?
    Wong, Peter K. K.
    RHEUMATOLOGY INTERNATIONAL, 2016, 36 (11) : 1535 - 1542
  • [37] Will we have and why do we need an Ebola vaccine?
    Klenk, HD
    NATURE MEDICINE, 2000, 6 (12) : 1322 - 1323
  • [38] Genetics of rheumatoid arthritis: what have we learned?
    Marieke Bax
    Jurgen van Heemst
    Tom W. J. Huizinga
    Rene E. M. Toes
    Immunogenetics, 2011, 63 : 459 - 466
  • [39] Genetics of rheumatoid arthritis: what have we learned?
    Bax, Marieke
    van Heemst, Jurgen
    Huizinga, Tom W. J.
    Toes, Rene E. M.
    IMMUNOGENETICS, 2011, 63 (08) : 459 - 466
  • [40] Difficult-to-treat rheumatoid arthritis: what have we learned and what do we still need to learn?
    Hofman, Zonne L. M.
    Roodenrijs, Nadia M. T.
    Nikiphorou, Elena
    Kent, Alison L.
    Nagy, Gyorgy
    Welsing, Paco M. J.
    van Laar, Jaap M.
    RHEUMATOLOGY, 2024, 64 (01) : 65 - 73